Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5195 ARTÍCULOS , VIENDO DEL 1981 AL 1995

Brain-first versus body-first Parkinson's disease: a multimodal imaging case-control study

Horsager J, Andersen KB, Knudsen K, Skjærbæk C, Fedorova TD, Okkels N, Schaeffer E, Bonkat SK, Geday J, Otto M, Sommerauer M, Danielsen EH, Bech E, Kraft J, Munk OL, Hansen SD, Pavese N, Göder R, Brooks DJ, Berg D, Borghammer P.

Brain. 2020 Oct 1;143(10):3077-3088. doi: 10.1093/brain/awaa238.

GDNF clinical trials for Parkinson's disease: a critical human dimension

Gash DM, Gerhardt GA, Bradley LH, Wagner R, Slevin JT.

Cell Tissue Res. 2020 Oct;382(1):65-70. doi: 10.1007/s00441-020-03269-8. Epub 2020 Aug 24.

Prefrontal Cortex Activity and Gait in Parkinson's Disease With Cholinergic and Dopaminergic Therapy

Stuart S, Morris R, Giritharan A, Quinn J, Nutt JG, Mancini M.

Mov Disord. 2020 Nov;35(11):2019-2027. doi: 10.1002/mds.28214. Epub 2020 Aug 24.

Foods with Potential Prooxidant and Antioxidant Effects Involved in Parkinson's Disease

Miranda-Díaz AG, García-Sánchez A, Cardona-Muñoz EG.

Oxid Med Cell Longev. 2020 Aug 3;2020:6281454. doi: 10.1155/2020/6281454. eCollection 2020.

Diabetes Mellitus and Parkinson's Disease: Shared Pathophysiological Links and Possible Therapeutic Implications

Hassan A, Sharma Kandel R, Mishra R, Gautam J, Alaref A, Jahan N.

Cureus. 2020 Aug 18;12(8):e9853. doi: 10.7759/cureus.9853.

[Human cells for therapeutics purpose: State of the art]

Guilhot F.

Bull Acad Natl Med. 2020 Oct;204(8):866-876. doi: 10.1016/j.banm.2020.07.051. Epub 2020 Jul 21.

[Rapidly progressive dementia due to neurosyphilis (general paralysis). A treatable case of dementia]

Paviolo JP, Imbach MC, Nocenti ZA, Durand BL.

Medicina (B Aires). 2020;80(4):401-404.

[DIFFERENTIAL DIAGNOSIS AND THERAPY OF PARKONSON'S DISEASE AND ESSENTIAL TREMOR: REVIEW AND CLINICAL CASE]

Utegenova A, Utepkaliyeva A, Kabdrakhmanova G, Khamidulla A, Urasheva Z, Ahmadeeva L.

Georgian Med News. 2020 Jun;(303):86-92.

Effect of Cycling Thalamosubthalamic Stimulation on Tremor Habituation and Rebound in Parkinson Disease

Enatsu R, Kitagawa M, Morishita T, Sasagawa A, Kuribara T, Hirano T, Arihara M, Mikami T, Mikuni N.

World Neurosurg. 2020 Dec;144:64-67. doi: 10.1016/j.wneu.2020.08.141. Epub 2020 Aug 22.

Sleep and cognition in Parkinson's disease

Amara AW.

Sleep Med. 2020 Sep;73:179-180. doi: 10.1016/j.sleep.2020.07.025. Epub 2020 Aug 4.

Nanoparticle-Based Technology Approaches to the Management of Neurological Disorders

Sim TM, Tarini D, Dheen ST, Bay BH, Srinivasan DK.

Int J Mol Sci. 2020 Aug 23;21(17):6070. doi: 10.3390/ijms21176070.

Preparation and Neuroprotective Activity of Glucuronomannan Oligosaccharides in an MPTP-Induced Parkinson's Model

Liu Y, Jin W, Deng Z, Wang J, Zhang Q.

Mar Drugs. 2020 Aug 23;18(9):438. doi: 10.3390/md18090438.

Personalized care management for persons with Parkinson's disease: A telenursing solution

Mancini F, van Halteren AD, Carta T, Thomas S, Bloem BR, Darweesh SKL.

Clin Park Relat Disord. 2020;3:100070. doi: 10.1016/j.prdoa.2020.100070. Epub 2020 Aug 19.

A comparison between Parkinson's medication errors identified through retrospective case note review versus via an incident reporting system during hospital admission

Mill D, Bakker M, Corre L, Page A, Johnson J.

Int J Pharm Pract. 2020 Dec;28(6):663-666. doi: 10.1111/ijpp.12668. Epub 2020 Aug 25.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias